← Open Payments lookup

EDILIA GOMES: Open Payments

NPI 1992860571 · MELROSE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,442 in 35 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $712 · 2025 $1,442

Food & beverage: $1,304Education: $138
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$385
Vanda Pharmaceuticals Inc.9$278
Otsuka America Pharmaceutical, Inc.6$198
Teva Pharmaceuticals USA, Inc.5$190
Axsome Therapeutics, Inc.1$125
Lundbeck LLC4$106
Otsuka Pharmaceutical Development & Commercialization, Inc.1$78
Takeda Pharmaceuticals U.S.A., Inc.2$52
ABBVIE INC.1$30

Products named: CAPLYTA, REXULTI, FANAPT, Auvelity, AUSTEDO XR, TRINTELLIX, VRAYLAR.

Industry payments across MA — which companies pay providers there.